Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: Use of an Ocular Telemetry Sensor in Diamox Treated Patients [NA]
A clinical trial update reports on the use of an ocular telemetry sensor in patients treated with Diamox (acetazolamide) for glaucoma or ocu…
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination [Phase 4]
Phase 4 trial evaluating intraocular pressure reduction with the fixed combination of bimatoprost and timolol in glaucoma and ocular hyperte…
-
CLINICAL_TRIALS trial_result · 2010-10-22Clinical Trial Update: Tolerance and Effect on Intraocular Pressure After Administration of SYL040012 [Phase 1]
Phase 1 trial assessing tolerability and intraocular pressure effects of SYL040012 in ocular hypertension and glaucoma; study completed.
-
CLINICAL_TRIALS trial_result · 2010-10-20Clinical Trial Update: Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial assessing patient satisfaction with Timolol in adults with open-angle glaucoma or ocular hypertension; results have been poste…
-
CLINICAL_TRIALS trial_result · 2010-09-22Clinical Trial Update: A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs
This clinical trial update reports results from a comfort survey in patients with open-angle glaucoma or ocular hypertension who were treate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-08-31FDA Approved: LUMIGAN — Original Application (Allergan, Inc.)
The FDA approved Lumigan (bimatoprost) from Allergan, Inc. as an original application for lowering intraocular pressure in adults with open-…
-
FDA approval · 2010-08-31FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for latanoprost filed by Mylan Pharmaceuticals, approving a generic version of latanoprost for l…
-
FDA approval · 2010-08-13FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Alphagan P (brimonidine tartrate) from Allergan, Inc., likely involving labeling changes or …
-
FDA approval · 2010-08-03FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for brimonidine tartrate submitted by Sandoz Inc., representing a regulatory update to the product.
-
FDA approval · 2010-07-29FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for latanoprost submitted by Mylan Pharmaceuticals Inc.
-
FDA approval · 2010-06-18FDA Approved: COSOPT — Supplemental Application (Thea Pharma Inc.)
FDA approved a supplemental application for COSOPT (dorzolamide hydrochloride and timolol maleate) from Thea Pharma Inc., indicating approva…
-
CLINICAL_TRIALS trial_result · 2010-05-24Clinical Trial Update: Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular Hypertension [Phase 3]
This completed Phase 3 randomized trial compared selective laser trabeculoplasty (SLT) with argon laser trabeculoplasty (ALT) in patients wi…
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Safety and Efficacy of a Glaucoma Drug Delivery System [Phase 2]
Phase 2 clinical trial assessing the safety and effectiveness of a glaucoma drug delivery system completed, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-04-12Clinical Trial Update: A Long-term Safety Study of Once-daily Travatan [Phase 3]
Long-term safety results from a Phase 3 study evaluating once-daily Travatan (latanoprost) in open-angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: Bimatoprost Versus Travoprost at Cairo University
This completed Cairo University trial compares the effectiveness and safety of the prostaglandin analogs bimatoprost versus travoprost in gl…
-
CLINICAL_TRIALS trial_result · 2010-03-11Clinical Trial Update: A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension [Phase 4]
Final results from a Phase IV study of a fixed-dose combination of travoprost and brinzolamide for glaucoma or ocular hypertension have been…
-
CLINICAL_TRIALS research · 2010-03-11Clinical Trial Update: Efficacy Comparison of Xalatan and Azopt on POAG and OH [NA]
A clinical trial update comparing Xalatan (latanoprost) and Azopt (brinzolamide) for primary open-angle glaucoma and ocular hypertension, wi…
-
CLINICAL_TRIALS trial_result · 2010-02-12Clinical Trial Update: Equivalence Study of Dorzolamide 2% Eye Drops Solution [Phase 3]
Phase 3 equivalence study evaluating dorzolamide 2% eye drops has been completed.
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial comparing single-dose comfort of Travatan Z in one eye to Xalatan in the other eye in patients with open-angle glaucoma or ocu…
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED) [Phase 4]
Phase 4 trial evaluating Cosopt (dorzolamide/timolol) over 8 weeks in patients with open-angle glaucoma or ocular hypertension has completed…
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension [Phase 4]
A Phase 4 trial comparing Travatan (travoprost) with Timoptic (timolol) for open-angle glaucoma or ocular hypertension has completed and pos…
-
CLINICAL_TRIALS trial_result · 2010-01-21Clinical Trial Update: Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom
Non-interventional study on patients with ocular hypertension and open-angle glaucoma treated with Xalatan and Xalacom; completed with resul…
-
CLINICAL_TRIALS trial_result · 2010-01-08Clinical Trial Update: Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 4]
A Phase 4 study of Travatan (travoprost) and Cosopt (dorzolamide/timolol) for primary open-angle glaucoma or ocular hypertension was termina…
-
FDA approval · 2009-11-18FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Sandoz Inc)
The FDA approved a generic dorzolamide hydrochloride and timolol maleate ophthalmic solution from Sandoz for lowering intraocular pressure i…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation [Phase 3]
Phase 3 trial evaluating the pharmacodynamics of Tafluprost 0.0015% eye drops, comparing preserved and unpreserved formulations.